 |
choline tetrathiomolybdate |
|---|---|
| Trade Name | |
| Orphan Indication | Wilson’s disease |
| USA Market Approval | USA |
| USA Designation Date | 2011-08-25 00:00:00 |
| Sponsor | Wilson Therapeutics AB;Strandvagen 5b, 114 51 Stockholm, Sweden; |
| |
choline tetrathiomolybdate |
|---|---|
| Trade Name | |
| Orphan Indication | Wilson’s disease |
| USA Market Approval | USA |
| USA Designation Date | 2011-08-25 00:00:00 |
| Sponsor | Wilson Therapeutics AB;Strandvagen 5b, 114 51 Stockholm, Sweden; |